section name header

Indications

High Alert

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: bradycardia, hypotension, hypertension.

Derm: flushing.

GI: abdominal cramping, hiccups, nausea, vomiting.

GU: discoloration of urine (green).

Local: burning, pain, stinging, coldness, numbness, tingling at IV site.

MS: involuntary muscle movements, perioperative myoclonia.

Neuro: dizziness, headache.

Resp: apnea, cough.

Misc: fever, PROPOFOL INFUSION SYNDROME.

Interactions

Drug-Drug:

Availability

(Generic available)

Route/Dosage

see Calculator

General Anesthesia

Monitored Anesthesia Care Sedation

ICU Sedation

US Brand Names

Diprivan

Action

Therapeutic Effects:

Classifications

Therapeutic Classification: general anesthetics

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Rapidly and widely distributed. Crosses the blood-brain barrier well; rapidly redistributed to other tissues.

Protein Binding: 95–99%.

Metabolism/Excretion: Rapidly metabolized by the liver. Primarily excreted in urine as metabolites.

Half-life: 3–12 hr (blood-brain equilibration half-life 2.9 min).

Time/Action Profile

(loss of consciousness)

ROUTEONSETPEAKDURATION†
IV40 secunknown3–5 min

†Time to recovery is 8 min (up to 19 min if opioid analgesics have been used).

Patient/Family Teaching

Pronunciation

PROE-poe-fol

Code

NDC Code*